Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH.
Tefferi A, et al.
Blood. 2002 May 15;99(10):3854-6. doi: 10.1182/blood-2001-12-0154.
Blood. 2002.
PMID: 11986248
Free article.
Clinical Trial.